The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology (original) (raw)
Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97(1):72–81. ArticlePubMedCAS Google Scholar
Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94(2):153–156. ArticlePubMedCAS Google Scholar
Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5–S16. ArticlePubMed Google Scholar
Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clinics in Liver Disease 2005;9:191–211. ArticlePubMed Google Scholar
Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, et al. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology 2003;38:1393–1400. PubMed Google Scholar
De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol 2002;193:59–63. ArticlePubMed Google Scholar
Rogers AB, Theve EJ, Feng Y, Fry RC, Taghizadeh K, Clapp KM, et al. Hepatocellular carcinoma associated with liver-gender disruption in male mice. Cancer Res 2007;67:11536–11546. ArticlePubMedCAS Google Scholar
Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004;127(5 suppl 1):S17–S26. ArticlePubMed Google Scholar
Jepsen P, Vilstrup H, Tarone RE, Friis S, Sorensen HT. Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends. Int J Cancer 2007;121(7):1624–1626. ArticlePubMedCAS Google Scholar
El-Serag HB, Mason HC. Rising incidence of hepatocellular carcinoma in the Unites States. N Engl J Med 1999;19:221–229. Google Scholar
Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ. Mortality and hospital utilization for hepatocellular cancer in the United States. Gastroenterology 2005;129:486–493. PubMed Google Scholar
El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Archives of Internal Medicine 2007;167:1983–1989. ArticlePubMed Google Scholar
Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, et al. Liver Cancer Network. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003;98(9):2060–2063. ArticlePubMed Google Scholar
Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004;127(5 suppl 1):S72–S78. ArticlePubMedCAS Google Scholar
Zhang Y-J, Chen Y, Ahsan H, Lunn RM, Chen S-Y, Lee PH, et al. Silencing glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular cancer. Cancer Lett 2005;221:135–143. ArticlePubMedCAS Google Scholar
Hoque A, Patt YZ, Yoffe B, Groopman JD, Greenblatt MS, Zhang YJ, et al. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States? Nutr Cancer 1999;35:27–33. ArticlePubMedCAS Google Scholar
La Vecchia C. Alcohol and liver cancer. Eur J Cancer Prev 2007;16:495–497. PubMed Google Scholar
Hara M, Tanaka K, Higaki Y, Mizuta T, Eguchi Y, Yasutake T, et al. Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci 2008;99:93–97. PubMedCAS Google Scholar
Chiu HF, Ho SC, Wang LY, Wu TN, Yang CY. Does arsenic exposure increase the risk for liver cancer? J Toxicol Environ Health Part A 2004;67:1491–1500. ArticlePubMedCAS Google Scholar
Cotrim HP, Carvalho F, Siquiera AC, Lordelo M, Rocha R, De Freitas LA. Nonalcoholic fatty liver and insulin resistance among petrochemical workers. JAMA 2005;294:1618–1620. ArticlePubMedCAS Google Scholar
Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007;22:1104–1111. ArticlePubMed Google Scholar
Yu M-W, Yeh S-H, Chen P-J, Liaw Y-F, Lin C-L, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97:265–272. ArticlePubMedCAS Google Scholar
Changchien C-S, Chen C-L, Yen Y-H, Wang J-H, Hu T-H, Lee C-M, et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcomes and survival. J Gastroenterol 2008;43:159–170. ArticlePubMedCAS Google Scholar
Brechot C, Jaffredo F, Lagorce D, Gerken G, Meyer zum Buschenfelde K, Papakonstontinou A, et al. Impact of HBV, HCV, and GBV-C/HGV on hepatocellular carcinoma in Europe: results of a European concerted action. J Hepatol 1998;29:173–183. ArticlePubMedCAS Google Scholar
Park J-W. Hepatocellular carcinoma in Korea: introduction and overview. Korean J Gastroenterol 2005;45:217–226. PubMed Google Scholar
Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112(2):463–472. ArticlePubMedCAS Google Scholar
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907–1917. ArticlePubMed Google Scholar
Bruix J, Sherman M. Management of hepatocellular carcinoma: AASLD Practice Guideline. Hepatology 2005;42:1208–1236. ArticlePubMed Google Scholar
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35–S50. ArticlePubMed Google Scholar
Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998;115:1216–1222. ArticlePubMedCAS Google Scholar
Watanabe S, Horie Y, Kataoka E, Sato W, Dohmen T, Ohshima S, et al. Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (Pten)-deficient mice. J Gastroenterol Hepatol 2007;22(suppl 1):S96–S100. ArticlePubMedCAS Google Scholar
Lew EA, Garfinkle L. Variation in mortality by weight among 750 000 men and women. J Chronic Dis 1979;32:563–76. ArticlePubMedCAS Google Scholar
Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13–21. ArticlePubMedCAS Google Scholar
Moller H, Mellemgaard A, Lindvig K, Olsen J. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344–350. ArticlePubMedCAS Google Scholar
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625–1638. ArticlePubMed Google Scholar
Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202–1219. ArticlePubMed Google Scholar
El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 2001;96:2462–2467. ArticlePubMedCAS Google Scholar
Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami H-O. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Nat Cancer Inst 2000;92:1096–1099. ArticlePubMedCAS Google Scholar
Yu L, Sloan DA, Guo C, Howell CD. Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000. Clin Gastroenterol Hepatol 2006;4:355–360. ArticlePubMed Google Scholar
Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S97–S103. ArticlePubMedCAS Google Scholar
Caldwell SH, Crespo DM. Milestones in liver diseases. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2005;40:578–584. Article Google Scholar
Ishii H. Hepatocellular carcinoma and non-alcoholic fatty liver disease: major liver diseases emerging from the Asia-Pacific Region. J Gastroenterol Hepatol 2006;21:6–7. ArticlePubMed Google Scholar
Park SH. Nonalcoholic steatohepatitis: pathogenesis and treatment. Korean J Hepatol 2008;14:12–27. ArticlePubMed Google Scholar
Lee V, Kleiner DE, Al-Osaimi AMS, Argo CK, Northup PG, Berg CL, et al. Histological characteristics of patients with “cryptogenic” cirrhosis and prior biopsy showing NASH. Hepatology 2007;46(suppl):743A. Google Scholar
Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349–1354. PubMed Google Scholar
Oh KC, Park SH, Park JC, Jin DK, Park CS, Kim KO, et al. Is the incidence of cryptogenic hepatocellular carcinoma increasing in Korea? Korean J Gastroenterol 2005;45:45–51. PubMed Google Scholar
Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other diseases. Hepatology 2005;42(1):5–12. ArticlePubMedCAS Google Scholar
Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer (Phila) 2003;97:3036–3043. Article Google Scholar
Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer (Phila) 2007;109:2490–2496. Article Google Scholar
Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 2008;6:459. ArticlePubMed Google Scholar
Takuma Y, Nouso K, Makino Y, Saito S, Takayama H, Takahara M, et al. Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma. Liver Int 2007;27(5):620–626. ArticlePubMed Google Scholar
Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003;163:1301–1311. PubMedCAS Google Scholar
Hu W, Feng Z, Eveleigh J, Iyer G, Pan J, Amin S, et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis (Oxf) 2002;23:1781–1789. ArticleCAS Google Scholar
Rossmanith W, Schulte-Hermann R. Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech 2001;52:430–436. ArticlePubMedCAS Google Scholar
Sanchez A, Factor VM, Schroeder IS, Nagy P, Thorgeirsson SS. Activation of NF-κB and STAT3 in rat oval cells during 2-acetylaminoflourene/partial hepatectomy-induced liver regeneration. Hepatology 2004;39:376–385. ArticlePubMedCAS Google Scholar
Sasaki Y. Does oxidative stress participate in the development of hepatocellular cancer? J Gastroenterol 2006;41:1135–1148. ArticlePubMedCAS Google Scholar
Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology (Oxf) 2006;49:138–151. ArticleCAS Google Scholar
Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in non-alcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007;133:80–90. ArticlePubMed Google Scholar
Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005:41:809–818. ArticlePubMedCAS Google Scholar
Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, et al. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 2008;47:511–520. ArticlePubMedCAS Google Scholar
Hytiroglou P, Park YN, Krinsky G, Theise ND. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin N Am 2007;36:867–887. Article Google Scholar
Roskams T. Liver stem cells and their implications in hepatocellular and cholangiocarcinoma. Oncogene 2006;25:3818–3822. ArticlePubMedCAS Google Scholar
Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 2003;94:851–857. ArticlePubMedCAS Google Scholar
Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, et al. A novel molecular classification of HCV-related hepatocellular carcinoma (HCC) based on integrative genomic analysis. J Hepatol 2008;48(S2):S12, EASL 2008. Article Google Scholar
Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008;299:53–60. ArticlePubMedCAS Google Scholar